Mellert W, Deckardt K, Gembardt C, Schulte S, Van Ravenzwaay B, Slesinski R
Experimental Toxicology and Ecology, BASF Aktiengesellschaft, Product Safety-Regulations, Toxicology and Ecology, Ludwigshafen/Rhein, Germany
Food Chem Toxicol. 2002 Nov;40(11):1581-8. doi: 10.1016/s0278-6915(02)00113-8.
Synthetic crystalline lycopene provides an alternative to extracts of naturally occurring lycopene for use in dietary supplements and functional foods. BASF Lycopene 10 CWD and Lyco Vit 10% formulated products each contain approximately 10% synthetic lycopene. These products were evaluated for toxicological and behavioral effects during a 13-week oral dosing study with male and female Wistar rats. Doses of 0, 500, 1500 and 3000 mg/kg body weight/day Lycopene CWD and 3000 mg/kg body weight /day Lyco Vit, as well as 3000 mg/kg body weight /day of the matrices used to formulate and stabilize each product, were administered by gavage to 10 rats/sex/day. A satellite group of five rats/sex received 0 or 3000 mg/kg body weight /day of each formulated product for an interim evaluation at 4 weeks of feeding. No statistically significant, dose-related effects on body weight, body weight gain, food consumption, hematology, urinalysis, clinical chemistry or ophthalmoscopic parameters were seen in any of the lycopene product or lycopene formulation matrix groups in comparison to the vehicle control group after 4 or 13 weeks of dosing. No deaths attributed to the test articles occurred during the study and the only clinical finding and at necropsy was the presence of red pigment in the feces and gastrointestinal tract that was associated with the red-pigmented test materials. No significant or dose-related abnormalities were found at necropsy or in microscopic evaluations of tissues collected at termination. Rats evaluated in home cages or in open field tests for behavioral and sensorimotor effects during the final week of the study showed no signs of treatment-related effects. The no-observed-adverse-effect level (NOAEL) for this study was concluded to be 3000 mg/kg body weight/day for both Lycopene CWD and Lyco Vit. The results of this study thus demonstrate the absence of any significant toxicological findings with Lycopene CWD and Lyco Vit products even at very high dose levels.
合成结晶番茄红素为膳食补充剂和功能性食品中使用的天然番茄红素提取物提供了一种替代选择。巴斯夫番茄红素10 CWD和番茄红素维生素10%配方产品各自含有约10%的合成番茄红素。在一项对雄性和雌性Wistar大鼠进行的为期13周的口服给药研究中,对这些产品的毒理学和行为学影响进行了评估。以0、500、1500和3000毫克/千克体重/天的剂量给予番茄红素CWD,以3000毫克/千克体重/天的剂量给予番茄红素维生素,以及以3000毫克/千克体重/天的剂量给予用于配制和稳定每种产品的基质,通过灌胃法给予每组10只大鼠/性别/天。一组每组5只大鼠的卫星组在喂养4周时接受0或3000毫克/千克体重/天的每种配方产品用于中期评估。与赋形剂对照组相比,在给药4周或13周后,任何番茄红素产品或番茄红素配方基质组中,在体重、体重增加、食物消耗、血液学、尿液分析、临床化学或眼科参数方面均未观察到具有统计学意义的剂量相关影响。在研究期间未发生归因于受试物的死亡,唯一的临床发现以及尸检结果是粪便和胃肠道中存在与红色素受试材料相关的红色色素。在尸检时或对研究结束时收集的组织进行显微镜评估时,未发现明显的或剂量相关的异常。在研究最后一周,在饲养笼或旷场试验中对大鼠的行为和感觉运动影响进行评估时,未发现与治疗相关的影响迹象。得出本研究中番茄红素CWD和番茄红素维生素的未观察到有害作用水平(NOAEL)均为3000毫克/千克体重/天。因此,本研究结果表明,即使在非常高的剂量水平下,番茄红素CWD和番茄红素维生素产品也未出现任何明显的毒理学发现。